5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

      Proceedings of the National Academy of Sciences of the United States of America
      Apoptosis, physiology, Base Sequence, Cell Cycle, Cell Division, Cysteine Endopeptidases, metabolism, DNA Primers, DNA-Binding Proteins, Dipeptides, chemistry, Genes, p53, Herpesvirus 4, Human, genetics, Humans, Molecular Sequence Data, Multienzyme Complexes, Neoplasm Proteins, Nuclear Proteins, Oligodeoxyribonucleotides, Antisense, Oncogene Proteins, Viral, Open Reading Frames, Osteosarcoma, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-mdm2, Recombinant Fusion Proteins, Repetitive Sequences, Amino Acid, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Ubiquitin

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Functional inactivation of the tumor suppressor protein p53 by accelerated ubiquitin/proteasome-dependent proteolysis is a common event in tumor progression. Proteasomal degradation is inhibited by the Gly-Ala repeat (GAr) of the Epstein-Barr virus nuclear antigen-1, which acts as a transferable element on a variety of proteasomal substrates. We demonstrate that p53 chimeras containing GAr domains of different lengths and positions within the protein are protected from proteolysis induced by the ubiquitin ligases murine double minute 2 and E6-associated protein but are still ubiquitinated and retain the capacity to interact with the S5a ubiquitin-binding subunit of the proteasome. The GAr chimeras transactivate p53 target genes, induce cell cycle arrest and apoptosis, and exhibit improved growth inhibitory activity in tumor cells with impaired endogenous p53 activity.

          Related collections

          Author and article information

          Comments

          Comment on this article